Search

everythinglearnresearchcommunity

for

Search:↓

Phosphorylation of certain parts of the PIN3 protein is crucial for its role in plant root growth and response to gravity.

A specific mutation in Kras causes abnormal tissue changes by making a cell signal continuously active, which disrupts normal cell coordination.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Adding a second method to PROTACs could improve cancer treatment.

AP-1 controls tumor cell type by affecting key signaling pathways.

Matrical tumors share a common growth mechanism involving the Wnt pathway and consistent PHLDA1 expression.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

IGFBP-rP1 could be a new treatment for a common type of hair loss.

Hairless protein and putrescine regulate each other, affecting hair growth and skin balance.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

Overexpressing PKCα in mice skin increases inflammation but doesn't affect tumor growth.

Mice with a specific BRCA1 mutation have a higher risk of tumors, especially in the uterus and ovaries.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

A mutation in the HOXC13 gene causes hair and nail problems in a Syrian family.

A mutation in the hairless gene speeds up severe itchy skin in mice on a special diet.

Auxin helps root hairs grow in high phosphate by affecting ROS and involving RSL2 and RSL4.

Certain mutations in the hairless protein disrupt its ability to regulate the hair cycle.

Vitamin A treatment reduced abnormal cell growth and improved skin conditions in rats with tumors.

Cortisol increases a specific protein in bone cells, which may help explain its negative effects on bone.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Protein kinase C epsilon may promote skin cancer development after UV exposure by affecting nearby cells.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

CXCR2 in skin cells promotes tumor growth.

Overexpressing PKCepsilon in mice reduces papillomas but increases carcinomas.

Researchers found key regions in the mouse hairless gene that control its activity in skin and brain cells, affecting hair follicle function.